-+ 0.00%
-+ 0.00%
-+ 0.00%

Entero Therapeutics Q2 EPS $(0.21) Up From $(3.86) YoY

Benzinga·08/14/2025 22:07:11
Listen to the news
Entero Therapeutics (NASDAQ:ENTO) reported quarterly losses of $(0.21) per share. This is a 94.56 percent increase over losses of $(3.86) per share from the same period last year.